COMP <GO>
CON vs MRK // 10Y YIELD & FRED MACRO BETA
Concentra Group Holdings Parent Inc. (NYSE) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: CON 4
— MRK 8
▲ 10Y YIELD & FRED MACRO BETA LEADER: CON
LAST: $40.33 (-0.12%) • MKT CAP: $5.15B
macro-sensitivity
1.00
LAST: $148.36 (-0.78%) • MKT CAP: $368.89B
macro-sensitivity
0.92
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CON VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CON | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 74.80% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 19.70% | 20.70% | -1.00 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 15.4x | 15.3x | +0.10 | MRK | /valuation <GO> |
| Free Cash Flow Yield | 3.75% | 3.42% | +0.33 | CON | /fcf-yield <GO> |
| Operating Margin | 15.40% | 34.30% | -18.90 | MRK | /operating-margins <GO> |
| Net Profit Margin | 7.70% | 28.10% | -20.40 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 13.90% | 1.30% | +12.60 | CON | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.61% | 2.26% | -1.65 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.53 | 5.19 | -2.66 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 65.4 | 56.3 | +9.06 | CON | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 1.00 | 0.92 | +0.08 | CON | /macro-sensitivity <GO> |
| Forward P/E Multiple | 26.5x | 18.4x | +8.10 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.15B | $368.89B | -$363.74B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CON REV | MRK REV | CON GROSS % | MRK GROSS % | CON FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.16B | $65.01B | — | 74.8% | $197.1M | $12.36B |
| FY 2024 | $1.90B | $64.17B | — | 76.3% | $210.3M | $18.10B |
| FY 2023 | $1.84B | $60.12B | — | — | $151.6M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CON // BETA 1.00
MRK // BETA 0.92